CAS No.:126-07-8
Name: (+)-Griseofulvin
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 200mg/kg (200mg/kg) | National Technical Information Service. Vol. AD277-689, | |
| mouse | LD50 | intravenous | 280mg/kg (280mg/kg) | Toxicology and Applied Pharmacology. Vol. 2, Pg. 44, 1960. | |
| mouse | LD50 | oral | > 50gm/kg (50000mg/kg) | Toxicology and Applied Pharmacology. Vol. 2, Pg. 44, 1960. | |
| mouse | LD50 | subcutaneous | > 12gm/kg (12000mg/kg) | Toxicology and Applied Pharmacology. Vol. 2, Pg. 44, 1960. | |
| rat | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | Toxicology and Applied Pharmacology. Vol. 2, Pg. 44, 1960. | |
| rat | LD50 | intravenous | 400mg/kg (400mg/kg) | BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE |
Nature. Vol. 182, Pg. 1320, 1958. |
| rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 215, 1982. |
Consensus Reports:
IARC Cancer Review: Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 , 1976,p. 153.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.
SAFETY PROFILE:
Hazard Codes of Griseofulvin (CAS NO.126-07-8):
T,
Xn
Risk Statements: 60-61-40-43-45
R60: May impair fertility.
R61: May cause harm to the unborn child.
R40: Limited evidence of a carcinogenic effect.
R43: May cause sensitization by skin contact.
R45: May cause cancer.
Safety Statements: 53-22-36/37/39-45
S53: Avoid exposure - obtain special instructions before use.
S22: Do not breathe dust.
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: WG9800000
Confirmed carcinogen with experimental neoplastigenic and teratogenic data. Poison by intravenous and intraperitoneal routes. Moderately toxic by subcutaneous route. Human mutation data reported. Experimental reproductive effects. Used as an antibiotic, pharmaceutical, and veterinary drug. When heated to decomposition it emits toxic fumes of Cl−.
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Josun International Limited
- Afine Chemicals Limited
- Dayang Chem (Hangzhou) Co.,Ltd.
- LIDE PHARMACEUTICALS LIMITED
- Cartoon Ingredients Co., Ltd
- NOVETE Biotechnology Co., Ltd
- HILARY GRAM PLC
- zhangwenfan
- Shaanxi King Stone Enterprise Company Limited
- SHAANXI TOP PHARM CHEMICAL CO.LTD
- Hubei Hengluyuang Technology Co.,Ltd
- Hubei Yikangyuan Chemical Co. Ltd
- INDO FRENCH LABORATORIES LTD
- Swiss Group of companies
- Wilhelm Beckmann
- hangzhou neway chemicals co., ltd.
- Indukern Hong Kong Ltd.
- Glosel Singapore Pte. Ltd.
- Sagran
- Umedica Laboratories Ltd.
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione

